Back to calendar
Crescent Biopharma, Inc. (CBIO) Earnings
CBIO reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.67
Actual EPS: $-0.74
EPS surprise: -0.58%
Company overview
Market Cap$659.3M
PriceUSD 17.75
EPS (TTM)-7.65
52-week high27.41
52-week low8.72
SectorHealth Technology
IndustryBiotechnology
Employees44